Micro-UltraSound In Cancer - Active Surveillance

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorUniversity of Alberta

About this trial

This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores. The primary goal is to compare microUS to MRI for the detection of ≥GG2 PCa at confirmatory biopsy. This study will also collect blood samples from participants to be used for future biomarker studies.

Eligibility criteria

Qualifiers

Adult men with Gleason Grade Group 1 prostate cancer managed by active surveillance who require a confirmatory prostate biopsy

Disqualifiers

Men who cannot undergo a prostate MRI

Men who cannot undergo a prostate biopsy

Trial design

Treatments tested in this trial

  • High-resolution micro-ultrasound

Treatment groups

210 Participants
are divided into 1 treatment group

Sponsors and collaborators